Although hepatitis E has emerged as a global health issue, there is limited knowledge of its infection biology and no FDA-approved medication is available. Aiming to investigate the role of protein kinases in hepatitis E virus (HEV) infection and to identify potential antiviral targets, we screened a library of pharmacological kinase inhibitors in a cell culture model, a subgenomic HEV replicon containing luciferase reporter. We identified protein kinase C alpha (PKCa) as an essential cell host factor restricting HEV replication. Both specific inhibitor and shRNA-mediated knockdown of PKCa enhanced HEV replication. Conversely, over-expression of the activated form of PKCa or treatment with its pharmacological activator strongly inhibited HEV replication. Interestingly, upon the stimulation by its activator, PKCa efficiently activates its downstream Activator Protein 1 (AP-1) pathway, leading to the induction of antiviral interferon-stimulated genes (ISGs). This process is independent of the JAK-STAT machinery and interferon production. However, PKCa induced HEV inhibition appears independent of the AP1 cascade. The discovery that activated PKCa restricts HEV replication reveals new insight of HEV-host interactions and provides new target for antiviral drug development.
Introduction
Hepatitis E virus (HEV) is one of the most common causes of acute viral hepatitis in the world. Although the mortality rate is <1% among the general population, pregnant women can have a fatality rate of up to 30% (Hakim et al., 2017) . Additionally, chronic hepatitis E has become a significant clinical problem in immunocompromised patients. Up to date, there is still no proven medication available and its infection biology is poorly understood.
Protein kinases are principal components of the machineries that orchestrate immune response against diverse pathogenic entities, including viruses, by subsequent stimulation of specific signal transduction cascades (Lupberger et al., 2011) . However, kinase controlled pathways employed by the host cells to stimulate antiviral immunity remain largely obscure. Knowledge of such pathways could prove exceedingly useful for the rational design of therapeutic avenues against HEV infection.
Encouragingly, numerous pharmacological kinase inhibitors or activators have been developed to target particular kinases. Among those, several are approved drugs in particular for treating cancer (Llovet et al., 2008) , and many are currently at various stages of preclinical and clinical development. These compounds have broad implications for treating various diseases, including cancer, inflammation, diabetes and viral infections (Rask-Andersen et al., 2014; Zhang et al., 2009 ).
Thus, this study aims to comprehensively profile kinasemediated cascades in celleautonomous antiviral immunity starting from screening a library of pharmacological kinase inhibitors in Huh7 based HEV replication cell model. We identified protein kinase C alpha (PKCa) as an important anti-HEV mediator. Concurrently, we also revealed a novel function of PKC-Activator Protein 1 (AP-1) pathway, serving as a non-canonical pathway to activate transcription of antiviral interferon-stimulated genes (ISGs).
Materials and methods

Reagents and antibodies
Stocks of phorbol 12-myristate 13-acetate (PMA) (SigmaAldrich, St Louis, MO) and JAK inhibitor I (Santa Cruz Biotech, Santa Cruz, CA) were dissolved in dimethyl sulfoxide (DMSO) (SigmaAldrich, St Louis, MO) to concentrations of 100 mg/ml and 20 mM, respectively. Antibodies including phospho-PKCa/b (#9375), phospho-STAT1 (58D6, #9167), c-Fos (9F6, #2250), RelA (C22B4, #4764), Anti-rabbit IgG(HþL),F(ab') 2 Fragment (Alexa Fluor 488 conjugate) and Anti-mouse IgG (HþL), F(ab')2 Fragment (Alexa Fluor ® 488 Conjugate) were purchased from Cell Signaling Technology, the Netherlands. Anti-rabbit or anti-mouse IRDye-conjugated antibodies were used as secondary antibodies for western blotting (Stressgen, Victoria, BC, Canada).
Viruses and cell culture models
Hepatocellular carcinoma cells Huh7 were kindly provided by Professor Bart Haagmans from Department of Viroscience, Erasmus Medical Center. Human Embryonic Kidney 293 cells were originally obtained from ATCC (www.atcc.org). The HEV infectious model (Huh7-P6) was based on Huh7 cells containing the full-length HEV genome (Kernow-C1 p6 clone, GenBank Accession Number JQ679013) (Wang et al., 2016a) . Infectious HEV particles are generated and secreted into cell culture medium, which can be collected and used for secondary infection (Shukla et al., 2011 (Shukla et al., , 2012 Wang et al., 2014; Zhou et al., 2014) . The HEV subgenomic model was based on Huh7 cells containing the subgenomic HEV sequence (Kernow-C1 p6/luc) coupled to a Gaussia luciferase reporter gene. HEV replication defective model was based on Huh7 cells transfected with in vitro transcribed RNA from MluI-linearized plasmids p6-luc-GAD (kindly provided by Suzanne U. Emerson). A mutation in the HEV polymerase results in defect of viral replication. ISRE, NF-kB, AP-1 luciferase reporter cells were generated by transducing Huh7 cells with lentiviral vectors expressing the firefly luciferase gene under the control of ISRE, NF-kB, AP-1 promoters, respectively (System Biosciences). For simian rotavirus, SA11, a well-characterized and broadly used laboratory strain, was used to inoculate the Caco2 cell line as a rotavirus infection model. Murine norovirus 1 (MNV-1) was used to infect RAW 264.7 cells as a norovirus infection model (Wobus et al., 2004) . The HIV virus production model was based on 293T cells transfected with HIV-1 molecular clone pLAI and pRL. The HIV single cycle entry model was based on TZM-bl cells infected with HIV clone Plai (van Bel et al., 2014) . For influenza virus, multicycle replication curves were generated by inoculating A549 cells at a multiplicity of infection (MOI) of 0.01 50 percent tissue culture infectious doses (TCID 50 ) of A/Netherlands/246/1978(A/H3N2) or A/Netherlands/602/09 (A/ H1N1) in duplicate. Supernatants were sampled at 0, 6, 12, 24, 48 and 72 h post inoculation, and virus titers in these supernatants were determined by means of end-point titration in MDCK cells as described previously (Schrauwen et al., 2013) .
Screen of pharmacological kinase inhibitors
The kinase inhibitor library used for the screening was made available by the KU Leuven Centre for Drug Design & Development (www.cd3.eu). Huh7 cells were seeded in 96-well plates at 7.5 Â 10 3 cells per well in 100 ml of DMEM with10% FBS and were incubated at 37 C. After 24 h, cell layers were washed and transfected with capped p6/luc RNA (100 ng per well [each] ) by use of DMRIE-C reagent (0.2 ml per well) according to the manufacturer's instructions. Plates were incubated at 37 C for 4 h. Afterwards, the transfection medium was removed. Cell layers were washed twice with PBS and 100 ml of compound (diluted to a final concentration of 100, 20, 4 and 0.8 mM, respectively, in DMEM with 10% FBS) was added to each well. For control wells, the compound was omitted. After incubation for 3 days, HEV replicon e related Gaussia luciferase values were measured accordingly . Cell viability (CV) caused by compound-specific side effects were also analyzed after 3 days by using the CellTiter 96 AQ ueous nonradioactive cell proliferation (monotetrazolium salt [MTS] ) assay (Promega) (de Wilde et al., 2014) . HEV replicon -related luciferase values were normalized with the following formula: Luc (Norm) ¼ (Luc replicon þ compound e Luc replicon þ control )/(CV replicon þ compound e CV replicon þ control ).
Gene knockdown or over-expression by lentiviral vectors
Lentiviral pLKO knockdown vectors (SigmaeAldrich) targeting PKCa, PKCb, IRF9, RelA, c-Fos or control were obtained from the Erasmus Biomics Center and produced in HEK293T cells as previously described (Pan et al., 2009) . After a pilot study, the shRNA vectors exerting optimal gene knockdown were selected. These shRNA sequences are listed in Supplementary Table 2. Stable gene knockdown cells were generated after lentiviral vector transduction and puromycin (2.5 mg/ml; Sigma) selection. wtPKCa and caPKCa overexpression lentivral vectors were a kind gift from Dr. Lin from the University of Minnesota. To create stable overexpression cell lines, GFP positive cells were sorted by cell sorter after lentiviral vectors transduction.
Reinfection assays
Reinfection assay was performed accordingly . Supernatant (containing infectious HEV particles) was collected from Huh7-P6 HEV model and purified by ultracentrifugation. The supernatant was first filtered through 0.45 mm filter followed by centrifugation at 10,000 rpm for 30 min to remove cell debris and then 22,000 rpm for 2 h to pellet HEV virus (SW 28 rotor). The pellet was suspended and diluted to 1 Â 10 7 HEV viral RNA copies/ ml. The diluted HEV virus stock was stored at À80 C. For HEV infection, cells were seeded into 12-well plates at a density of 7 Â 10 4 cells per well and incubated for 24 h. Next, cells were incubated with 400 ml HEV stock (1 Â 10 7 viral RNA copies/ml) per well at 37 C for 6 h. Then, the inoculum was removed, and cell layers were washed 3 times with PBS, and 1 ml fresh medium was added to each well.
Measurement of luciferase activity
For Gaussia luciferase, the secreted luciferase activity in the cell culture medium was measured by BioLux ® Gaussia Luciferase Flex Assay Kit (New England Biolabs). For firefly luciferase, luciferin potassium salt (100 mM; Sigma) was added to cells and incubated for 30 min at 37 C. Both Gaussia and firefly luciferase activity was quantified with a LumiStar Optima luminescence counter (BMG LabTech, Offenburg, Germany). 
Western blot assay
Cultured cells were lysed in Laemmli sample buffer containing 0.1 M DTT and heated 5 min at 95 C, followed by loading onto a 10% sodium dodecyl sulfate polyacrylamide gel and separation by electrophoresis. After 90 min running at 120 V, proteins were electrophoretically transferred onto a polyvinylidene difluoride membrane (Invitrogen) for 1.5 h with an electric current of 250 mA. Subsequently, the membrane was blocked with a mixture of 2.5 ml blocking buffer (Odyssey) and 2.5 ml phosphate-buffered saline containing 0.05% Tween 20. It was followed by overnight incubation with primary antibodies (1:1000) at 4 C. The membrane was washed 3 times followed by incubation for 1 h with IRDyeconjugated secondary antibody (1:5000). After washing 3 times, protein bands were detected with the Odyssey 3.0 Infrared Imaging System.
Confocal laser electroscope assay
Huh7 cells were seeded on glass coverslips. After 12 h, cells were washed with PBS, fixed in 4% formalin for 10 min and blocked with tween-milk-glycine medium (PBS, 0.05% tween, 5 g/ L skim milk and 1.5 g/L glycine). Samples were incubated with primary antibodies overnight at 4 C. Subsequently, samples were incubated with 1:1000 dilutions of the anti-mouse IgG (HþL), F(ab')2 Fragment (Alexa Fluor ® 488 Conjugate) or anti-rabbit IgG(HþL), F(ab') 2 Fragment (Alexa Fluor 488 conjugate) secondary antibodies. Nuclei were stained with DAPI (4,6-diamidino-2-phenylindole; Invitrogen). Images were detected using confocal electroscope.
Creation of mutant ISRE reporter cell line
Based on the sequence specific ISRE motif, a mutant version of ISRE was designed and synthesized (Forward: 5 0 - In the Huh7 cell-based subgenomic HEV replicon model, treatment with different doses of Go6976 increased HEV replication-related luciferase activity. Cells transfected with replicon defective control (HEV-luciferase-GAD) RNA were also treated with Go6976 (n ¼ 3 independent experiments with 2e3 replicates each). Data presented as mean ± SEM (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
aattcAGTCACGTCTTCCCTTTCAGTCACGTCTTCCCTTTCAGTCACGTCTTCCCTTTCAGTCACGTCTTCCCTTTa-3 0 ; Reverse: 5 0 -ctagtAAAGGGA-AGACGTGACTGAAAGGGAAGACGTGACTGAAAGGGAAGACGTGACTGAAAGGGAAGACGTGACTg-3 0 ), which shows no consensus sequence with AP-1 motif. EcoRI and SpeI sites are included (shown in italics) to facilitate directional cloning into the pGreenFire LentiReporter vector (System Biosciences). The recombinant plasmid was verified by restriction enzyme digestion and DNA sequencing. Stable mutant ISRE reporter cells were generated after the lentiviral vector transduction and puromycin (2.5 mg/ml; Sigma) selection.
C-Fos ChIP-seq data analysis
The c-Fos ChIP-seq data set with accession number GSM754332 was retrieved from the Gene Expression Omnibus. Sequence reads with low complexity that are unlikely to map uniquely to the genome were removed from the dataset using prinseq-lite with the dust method with 7 as threshold (Schmieder and Edwards, 2011; Wang et al., 2016b) . Bases on 5 0 and 3' end of the reads with a quality score below 28 were trimmed also using prinseq-lite. Trimmed reads were required to have a minimum length of 20 bases. The remaining sequences with a Phred score <70 were mapped to the hg38 reference genome using Bowtie v0.12.7 (Langmead and Jha, 2009 ), where we used a seed length of 36 in which we allowed a maximum of 2 mismatches. If a read had multiple alignments, only the best matching read was reported. Duplicated reads were removed. MACS v1.4.2 was used for peak calling using default settings. The sequencing profiles of c-Fos were created in the IGV browser (Robinson et al., 2011) .
MTT assay
Cells were seeded in 96-well plates and cultured at 37 C with 5% CO 2 for 24, 48, 72 h, respectively. Then 10 mM 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma) was added to cells and incubated for 4 h. Subsequently, medium was removed and 100 ml of DMSO was added to each well.
The absorbance of each well was read on a microplate absorbance readers (BIO-RAD) at a wavelength of 490 nm. All measurements were performed in triplicate.
Statistical analysis
All results were presented as mean ± SEM. Comparisons between groups were performed with Mann-Whitney test. Differences were considered significant at a P value less than 0.05. The change in amino acid sequence between wtPKCa and caPKCa is shown in the rectangular frame. (E) qRT-PCR analysis of cellular HEV RNA level in CTR, wtPKCa or caPKCa over-expressing cells after inoculation of infectious HEV particles for 72 h caPKCa over-expression inhibited HEV RNA by 49%. Data presented as mean ± SEM (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant).
Results
A screening for kinases identifies conventional PKCs as cellautonomous anti-HEV elements
Protein kinases are pivotal mediators of signal transduction and identifying kinases involved in biological responses can shed important light on kinase associated virus-host interactions. The lack of understanding as to which signal pathways mediate cellautonomous antiviral immunity against HEV thus prompted us to execute a screening of kinase inhibitors with respect to their effects in antiviral responses. To this end, we employed a hepatocyte cell ) qRT-PCR analysis of HEV RNA derived from Huh7 cells harboring the full-length HEV infectious genome. Treatment with PMA (100 ng/ml) for 48 h significantly inhibited cellular HEV RNA by 68% (n ¼ 9). (C) Huh7 cells harboring the full-length HEV infectious genome were treated with different doses of IFN-a, PMA or a combination of both for 48 h. Cellular HEV RNA level was determined by qRT-PCR. PMA and IFN-a showed comparable anti-HEV capacity, but they failed to exert further combined effect (n ¼ 4). (D) Same as (C) for ribavirin, PMA or a combination of both. The combination of PMA with ribavirin showed strong additive anti-HEV effect (n ¼ 4). (E) The Huh7 cell-based subgenomic HEV replicon was treated with PMA, IFN-a or a combination of both. Their combination showed no additive effect. Luciferase values were measured at 24, 48 and 72 h (n ¼ 3 independent experiments with 2e3 replicates each). (F) Same as (E) for PMA, ribavirin or a combination of both. Their combination showed additive anti-HEV activity. (n ¼ 3 independent experiments with 2e3 replicates each). Data presented as mean ± SEM (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant). (Fig. S1A and Table S1 ). We arbitrarily set the control luciferase value to 1 and identified 40 inhibitors (normalized value ! 1.2) that increase and 42 compounds (normalized value 0.8) that inhibit luciferase activity in this assay system (Fig. 1A and Table S2 ). Inhibition of luciferase activity might be due to non-specific effects not related to the scientific question at hand (e.g. effects on translation or cell survival). Strikingly, stimulation of luciferase activity likely relates to the inhibition of signaling elements involved in constraining viral replication and hence we concentrated on luciferase enhancing compounds in our search for elements involved in antiviral immunity. Go6976, a fairly specific inhibitor of the conventional PKCs (PKCa, PKCb І , PKCb ІІ , and PKCg) (Martiny-Baron et al., 1993) , has increased HEV luciferase activity. Subsequent western blot analysis for the phosphorylation state of PKC isoforms confirmed the inhibition of PKCa and PKCb by Go6976 in our experimental system (Fig. 1B) . HEV promoting activity of Go6976 was further confirm in two independent cell culture models: a subgenomic HEV containing luciferase reporter and a full-length HEV infectious cell culture system (Fig. 1C, D and Fig. S1B ). Go6976 showed inhibitory effect on host cell growth (Fig. S1C) , which is expected because of the crucial roles of PKCs in cell physiology. Interestingly, Go6976 is also indicated as a potential inhibitor of protein kinase D (PKD), although with relatively lower sensitivity compared with PKCa and PKCb1. Therefore, we also tested the role of PKD in Go6976 induced HEV replication. CID 755673, a selective PKD inhibitor (IC 50 : 0.182e0.227 mM) was tested in both HEV cell culture systems. However, CID 755673 showed no significant effect on HEV replication ( Fig. S1D and E) . Therefore, the effect of Go6976 on HEV is likely independent of PKD. Collectively, these data demonstrated that conventional PKCs are important antiviral elements, at least with respect to HEV infection.
PKCa is the key anti-HEV isoform
The observation that conventional PKCs constrain HEV replication raises questions as to the role of different PKC isoforms. To dissect the effects of individual PKC isoforms, we silenced the . Data presented as mean ± SEM (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant).
no effect on PMA induced ISRE-related luciferase activation, as measured at 48 and 72 h (n ¼ 3 independent experiments with 2e3 replicates each). (J) Knockdown of IRF9 in the Huh7 based ISRE luciferase reporter cells blocks IFN-a (1 IU/ml) induced ISRE-related luciferase activation, as measured at 48 and 72 h (n ¼ 3 independent experiments with 2e3 replicates each). Date presented as mean ± SD (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant). expression of PRKCA (the gene coding for PKCa) and PRKCB (that gives rise to PKCb І and PKCb ІІ ) in Huh7 cells using lentiviralmediated RNAi. Since PKCg has been shown to be specifically expressed in neuronal tissue (Martiny-Baron and Fabbro, 2007) , we ruled it out for further research. Western blot and qRT-PCR confirmed successful down-regulation of PKC isoforms ( Fig. 2A and B) at protein and RNA levels. Subsequently, cells were inoculated with infectious HEV particles and cellular HEV RNA was quantified by qRT-PCR after 48 h. Knockdown of PKCa led to a 2.25 ± 0.3 fold (n ¼ 4, p < 0.05) increase of HEV RNA; whereas PKCb knockdown resulted in no significant effect (Fig. 2C) , suggesting that PKCa is the relevant isoform here.
PKCa maintains its inactive state via an inhibitory region within the effector binding domain of the kinase. Its pseudosubstrate site mediates this inhibition by binding to the active site and preventing substrate interaction (House and Kemp, 1987) . A constitutively active PKCa (caPKCa) is available in which a glutamic acid present in this region is substituted for alanine. (Fig. 2D) . This form dramatically increases effector-independent kinase activity, compared to the wild-type PKCa (wtPKCa) (Pears et al., 1990) . Huh7 cells were transduced with integrating lentiviral vectors coexpressing GFP and caPKCa or wtPKCa (Fig. S1F) . Cell cytometry confirmed transgene expression by measuring GFP and positive cells were sorted and expanded for further experimentation (Fig. S1G ). Huh7 cells expressing caPKCa or wtPKCa were inoculated with infectious HEV particles and relative viral RNA level was quantified 48 h post-inoculation. Consistent with PKCa knockdown (Fig. 2C) , expression of caPKCa significantly decreased HEV RNA by 49% (n ¼ 4, p < 0.05), while wtPKCa over-expression showed no effect on HEV compared to control sample (Fig. 2E) .
This promising result prompted us to investigate the potential role of the classical PKC pharmacological activator, PMA, also commonly known as 12-O-Tetradecanoylphorbol-13-acetate (TPA). PMA, structurally analogous to diacylglycerol, is commonly used to activate PKC. It is also a promising drug candidate, currently under a Phase II clinical trial for the treatment of patients with relapsed/ refractory acute myelogenous leukemia (NCT01009931). As expected, PMA exerted strong anti-HEV effects in both HEV subgenomic and full-length infectious models (Fig. 3A and B and Fig. S2A, B) ; while no clear effect on cell growth and viability was observed (Fig. S2C ). This result prompted us to assess the combined antiviral effect of PMA with the off-label anti-HEV drugs IFN-a or ribavirin Todt et al., 2016; Zhou et al., 2016) . Although PMA and IFN-a showed comparable anti-HEV capacity, they failed to exert further combined effect ( Fig. 3C and E) . The combination of PMA with ribavirin showed strong additive anti-HEV effect (Fig. 3D and F) . These data collectively indicate that activated PKCa plays an important role in cell-autonomous anti-HEV immunity.
PKCa provokes transcriptional activation of ISGs, independent of the IFN-JAK-STAT pathway
We extended our study on a list of other viruses (rotavirus, murine norovirus, HIV-1 and influenza virus). Although no significant antiviral effects on HIV-1 and influenza virus, PMA significantly inhibited rotavirus and murine norovirus 1 infection (Fig. S2B -G) . The relative broad antiviral efficacy induced by PMA prompted us to investigate its potential link to the function of IFNs, which possess broad antiviral effects via efficient induction of ISGs.
Following interferon stimulation and interferon receptor activation, STAT1 and STAT2 are phosphorylated and form heterodimers, which subsequently bind to IRF9 leading to the formation of the so-called IFN-stimulated gene factor 3 (ISGF3) complex. ISGF3 translocates to the nucleus and binds to the DNA specific sequence motif [5 0 -CAGTTTCACTTTCC-3 0 ], ISREs, to drive the expression of ISGs, which are the ultimate antiviral effectors of the interferon cascade (Fig. 4A) (Ohmori and Hamilton, 1993) . As expected, employing a Huh7 stably transfected ISRE-driven luciferase reporter cell line (Pan et al., 2011), we observed the induction of luciferase activity with IFN-a stimulation (Fig. 4A) . Surprisingly, forced activation of PKC, using the PMA stimulus, also provokes transactivation of ISRE elements (Fig. 4B) . Further confirmation was obtained by quantification of a panel of well-known antiviral ISGs (Fig. 4C) . Importantly, when the ISRE reporter cell line was transduced with integrating lentiviral vectors expressing shRNA specifically targeting PKCa, b or a control shRNA (shCTR), PKCa silencing resulted in a significant decrease of ISRE luciferase activity compared with shCTR control; whereas PKCb knockdown did not significantly affect ISRE activity (Fig. 4D ). These data demonstrate that PMA activates PKCa to mediate the transcriptional activity of ISRE, resulting in the induction of antiviral ISGs.
Signal transduction of the IFN-a/b receptor appears kaleidoscopic in that multiple discrete signaling cassettes are activated. An important effector is phosphatidylinositol-3OH-kinase (PI3) kinase, a major regulator of cellular signaling. Activation of PI3 kinase in turn leads to the activation of various effector pathways in different cell types, including 3-phosphoinositide dependent protein kinase (PDK), Protein kinase B (PKB), mechanistic target of rapamycin (mTOR) and PKC (Fig. S3B) (Kaur et al., 2005) . As PI3 kinase signaling and other signaling cassettes downstream of the interferon receptors may (in)directly crosstalk with PKCa, we investigated possible effects of IFN-a on PKC activation. As determined by western blot, PKC a/b
are not activated upon IFN-a challenge (1000 IU/ml; Fig. S3C ). Thus, PKCa activation is not the downstream effect of the IFN receptor.
To further investigate whether PKCa activation results in direct ISRE activation or whether indirect autocrine/paracrine mechanisms are responsible, we investigated possible PMA effects on the expression of type I interferons. PMA treatment did not increase IFN-a mRNA but even slightly decreased IFN-b1 expression (Fig. 4E) . In apparent agreement, incubation with the pan-JAK inhibitor I abrogated STAT1 phosphorylation and the induction of ISRE-regulated luciferase activity in Huh7 cells even following high dose IFN-a treatment (1000 IU/ml) ( Fig. S3D and E) , but did not diminish PMA-induced ISRE activation (Fig. 4F) . Furthermore, PMA did not affect STAT1 phosphorylation or IFN-a induced STAT1 activation at amino acid 701 (Y701P), which is an indispensable signature of STAT1 activation (Fig. 4G) . We further examined the role of IRF9, a key downstream element antiviral effector of the interferon pathway. As expected, PMA-induced ISRE luciferase activity was not affected in IRF9 knockdown cells compared to the shCTR control ( Fig. 4H and I) ; whereas IFN-a induced activation was . Data presented as mean ± SEM (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) clearly impaired ( Fig. 4J and Fig. S3F ). These results collectively indicate that PKCa-induced ISRE activation is independent of the classical interferon pathway.
3.4. PKCa mediated ISG transcriptional activation and anti-HEV effect is independent of the NF-kB pathway NF-kB signaling is a central pathway involved in cellular innate immune response. PMA can activate NF-kB signaling via the phosphorylation of NF-kB/p65 by PKCa (Chang et al., 2005; Jiang et al., 2010; Mut et al., 2010) . Thus, we investigated the potential involvement of NF-kB pathway. To this end, we used a lentiviral transcriptional reporter system expressing the firefly luciferase gene under the control of NF-kB responsive promoter. Huh7 cells were transduced with the vector to create a stable NF-kB reporter cell line. As expected, stimulation with PMA led to the strong activation of NF-kB luciferase activity (Fig. 5A) and thus a role of NFkB signaling cannot be ruled out. Thus, the Huh7 cell line was transduced with integrating lentiviral shRNA vectors to silence RelA (P65), an essential subunit of the NF-kB transcription complex, resulting in profound down-regulation of RelA expression ( Fig. 5B and C). These cells, however, still showed ISRE-driven luciferase activation (Fig. 5D) . Consistently, PMA induced anti-HEV effect was not abrogated in RelA knockdown cells (Fig. 5E ). Thus, NF-kB signaling appears not to be involved in PKCa mediated ISG transcriptional activation and anti-HEV effect.
3.5. PKCa/AP1 represents a non-canonical mechanism of activating ISG transcription, but is dispensable for PKCa-mediated anti-HEV activity AP-1 signaling is another important pathway involved in cellular innate immune response. PMA can also activate AP1 signaling via the activation of PKCa (Hwang et al., 2010; Langlet et al., 2010) . Indeed, PMA stimulation provokes a strong induction of c-Fos, an essential subunit of the AP1 transcription complex (Fig. 6A) . Accordingly, unstimulated cells displayed hardly detectable c-Fos protein, but c-Fos was substantially induced and translocated to nucleus following PMA stimulation (Fig. 6B) . Convincingly, we also used a lentiviral transcriptional reporter system expressing the firefly luciferase gene under control of an AP-1 responsive promoter. Huh7 cells were transduced with the vector to create a stable AP-1 reporter cell line. As shown in Fig. 6C , stimulation with PMA led to the strong activation of AP-1 luciferase activity. Thus, to determine the role of AP-1 activation, Huh7 cells were transduced with integrating lentiviral RNAi vectors to silence c-Fos (Fig. 6D and E) . Surprisingly, PMA induced ISRE activation was abrogated in c-Fos knockdown cells (Fig. 6F) . Consistently, the induction of ISGs by PMA was also sensitive to c-Fos knockdown (Fig. 6G) . Thus, AP-1 appears essential for PKCa-mediated ISRE activation.
Upon signaling activation, the transcription factor, AP-1, can bind to the sequence specific palindromic AP-1 site [5'-(A/T)T(G/ T)(A/C)(G/C)TCA(G/C/A)-3'] to promote gene transcription (Colin et al., 2011; Hess et al., 2004) . The puzzling role of AP-1 in the transactivation of the ISRE led us to perform an in silico analysis comparing the ISRE motif and the AP-1 DNA binding site and surprisingly revealed a consensus sequence of these two motifs (Fig. 6H) . We thus hypothesized that AP-1 might bind to this consensus sequence within the ISRE motif to drive its transcription. To test this hypothesis, we retrieved genome wide c-Fos ChIP-Seq data from GEO database (GSM754332) and analyzed the data set using Integrative Genomics Viewer (IGV) (Fig. S4A) (Consortium, 2012; Robinson et al., 2011; Thorvaldsdottir et al., 2013) . Confirming our hypothesis, we found c-Fos binding to the promoter regions of a list of ISGs (Fig. S5) . To further confirm this notion, we mutated the consensus nucleotide sequence within the ISRE motif based on the lentiviral transcriptional reporter vector expressing the firefly luciferase gene driven by multiple ISREs, resulting in a mutant ISRE luciferase reporter vector that should not be capable of AP-1 binding. (Fig. S4B ). Huh7 cells were transduced with this vector to create a stable reporter cell line. As expected, PMA failed to activate this mutated ISRE (Fig. 6J) . Hence, AP-1 is capable of direct transactivation of the ISRE. Surprisingly, PMA mediated anti-HEV activity was not abrogated in c-Fos knockdown cells (Fig. 5K) , even though the ISRE activation and ISG induction was blocked. Thus, AP-1 mediated ISG induction appears not essential for PKCamediated anti-HEV activity.
Discussion
Protein kinases play pivotal roles in regulating immune responses either positively or negatively via regulating protein functions, signal transduction or other cellular processes (Georgel et al., 2010; Li et al., 2014; Lupberger et al., 2013) . This study comprehensively profiled kinase-mediated cascades in celleautonomous antiviral immunity via screening a library of pharmacological kinase inhibitors on Huh7 based HEV replication cell model. We identified PKCa as an important antiviral host factor and a targetable host factor for antiviral drug development. Both functional over-expression and pharmacological activation showed strong and comparable anti-HEV activity compared to IFN-a.
PMA, as a phorbol ester, binds to the C1 domain in the regulatory region of PKCs to promote their activation (Ono et al., 1989) . Although PMA was reported to have a potential tumor-promoting role in experimental skin cancer mouse models (Furstenberger et al., 1981) , its anti-cancer activity in fact has been extensively investigated in the clinic, including in patients with hematological malignancy, squamous cell carcinoma, renal cell carcinoma, ovarian teratocarcinoma, subcutaneous adenocarcinoma and prostate cancer (Schaar et al., 2006) . Cancer patients often suffer from depressed white blood cell and neutrophil counts because of chemotherapeutic drugs. PMA treatment has been shown to increase white blood cell and neutrophil counts towards a normal range with only mild and reversible side effects observed (Han et al., 1998) . A Phase I trial of treating hematologic cancer or bone marrow disorder with PMA has been successfully conducted at The State University of New Jersey (NCT00004058). The same institute is currently pursuing a Phase II trial plus dexamethasone & choline magnesium trisalicylate in the treatment of patients with relapsed/ refractory acute myelogenous leukemia (NCT01009931). An interesting link is that patients with leukemia or other cancers are prone to virus infections, including HEV (Geng et al., 2014; Motte et al., 2012; Pfefferle et al., 2012) . The potential clinical prospects of PMA or its derivatives may be of achieving "one stone two birds" effects: simultaneously combating cancer and virus.
An interesting point of this study is the discovery of a new mechanism in transcription of antiviral ISGs, although moderately. Classically, ISG induction was known to be initiated predominantly by the IFN-JAK-STAT pathway in cell-autonomous defense against viral infection. Upon phosphorylation, STAT1 and STAT2 forming a complex with IRF9, this ISGF3 complex translocates to the nucleus and binds to the ISRE to drive ISG transcription. Here, we demonstrated that activation of the PKCa/AP-1 cascade was able to moderately drive ISG transcription as well. This action is independent of IFN production and the canonical JAK-STAT machinery. AP-1 is a transcription complex mainly composed of c-Jun and c-Fos proteins forming a heterodimers through their leucine-zipper domains. The AP-1 dimers recognize the sequence specific response elements via the basic domain and regulate target genes involved in cell proliferation, differentiation and apoptosis (Zenz et al., 2008) . Surprisingly, we observed consensus sequence between the ISRE and the AP-1 DNA binding site. Using ChIP-Seq data analysis and loss-of-function mutagenesis assays, we firmly demonstrated that AP-1 could directly drive gene transcription through binding to the ISRE on the ISG promoter region. Of note, the ISG induction effect induced by the PKCa/AP1 pathway is moderate, this may explain its non-essential role for PKCa-mediated anti-HEV activity.
In conclusion, we identified PKCa as an important cellautonomous antiviral factor against HEV in host defense. In addition, we also revealed a non-canonical mechanism in transcriptional activation of ISGs, although this is dispensable for PKCamediated antiviral activity. These results provide valuable antiviral target and shed new insights of virus-host interactions.
